Font Size: a A A

The Changes Of Plasma Total Homocysteine In Type 2 Diabetic Patients And The Relationship Between Plasma Total Homocysteine And Diabetic Vascular Complications

Posted on:2008-05-22Degree:MasterType:Thesis
Country:ChinaCandidate:T T YuFull Text:PDF
GTID:2144360218460138Subject:Internal Medicine
Abstract/Summary:PDF Full Text Request
[OBJECTIVE]①To study plasma total homocysteine (tHcy) level in normal glucose tolerance(NGT)and type 2 diabetes mellitus(T2DM) subjects and search for contributing factor to tHcy .②To investigate the possible relationship between tHcy and diabetic vascular complications.[RESEARCH DESIGN AND METHODS]①One hundred and thirty-five subjects( fifty-five cases in NGT group , eighty cases in T2DM group) were enrolled in this cross section study. The height, weight, waist circumference, hip circumference, blood pressure were measured in all subjects, and calculated body mass index(BMI) and waist-hip ratio(WHR). Fasting plasma total homocysteine, fasting serum vitamin B12, fasting plasma folic acid were assessed. Oral glucose tolerance and insulin releasing test were performed to assess insulin secretion(area under the curve (AUC) and insulin sensitivity(HOMA-IR) was calculated). Lipid protein including total cholesterol(TC), triglycerides(TG), high density lipoprotein cholesterol (HDL-c) and low density lipoprotein cholesterol (LDL-c) , hemoglobin Alc (HbAlc), and uric acid(UA) were assessed at the same time.②Multiple stepwise regression analysis was used to study contributing factor of tHcy.③Logistic regression analysis was used to investigate the relationship between tHcy and diabetic vascular complications.[RESULTS]①Plasma tHcy in T2DM subjects (21.09±10.99μmol/L) was significantly high(P=0.000) than that in NGT (3.70±5.54μmol/L) .②Multiple stepwise regression analysis showed Ln AUCGlu and WC were important contributors to tHcy (Adj-R2=0.378, P =0.000).③The result of Logistic regression analysis was that tHcy(OR=1.109)and age(OR=1.146) were independent risk factors to diabetic macroangiopathy.[CONCLUSIONS]①The concentration of plasma tHcy increased in patients with type 2 diabetes and gender was not contributed to the concentration of tHcy②Glucose and WC were important contributors to tHcy in NGT and T2DM patient .③The value of tHcy was important contributor to diabetic macroangiopathy. [OBJECTIVE] To assess the changes of plasma total homocysteine (tHcy) concentration in T2DM with insulin intensive therapy.[RESEARCH DESIGN AND METHODS] A total of Sixty-eight type 2 diabetic patients were enrolled in the randomized control study. All subjects received insulin intensive therapy. They were randomly divided in two groups.①Insulin intensive therapy group(group A) was treated with insulin only for six month.②Patient in union therapy group(group B) was treated with insulin, vitaminB12 and folic acid for six month. Before treatment, the height, weight, waist circumference, hip circumference, blood pressure were measured in all subjects, and calculated body mass index(BMI) and waist-hip ratio(WHR). The fasting plasma total homocysteine, fasting serum vitamin B12, fasting plasma folic acid were assessed. Lipid protein including total cholesterol(TC), triglycerides(TG), high density lipoprotein cholesterol (HDL-c), low density lipoprotein cholesterol (LDL-c) , hemoglobin Alc (HbAlc), and uric acid(UA) were assessed at the same time. All variables were measured in all subjects after six months.[RESULTS]①Plasma tHcy level were no significant different between group A and group B before therapy(26. 31±11. 76/μmol/L and 19. 06 + 7. 27/μmol/L respectively, P>0.05).②There was no significant difference of tHcy level before(26.31 + 11.76μmol/L) and after treatment(24. 52 + 11. 47μmol/L) in group A (P>0.05). The tHcy level decreased markedly after taking vitaminB12 and folic acid in group B(19. 06 + 7. 27μmol/L(before treatment) and 13. 95 + 5. 57μmol/L(after treatment), P =0.031).③Plasam tHcy level in group B were significant lower than those in group A after treatment(13. 95±5. 57μmol/L(group B) and 24.52±11. 47μmol/L(groupA), P =0.004).[CONCLUSIONS]①There was no significant effect statistically on plasma tHcy level in T2DM with insulin intensive therapy only.②Based on insulin intensive therapy, the concentration of tHcy in T2DM could be reduced significantly by taking vitamin B12 and folic acid replacement therapy.
Keywords/Search Tags:Type 2 diabetes, Normal glucose tolerance, Plasma Total homocysteine, Body fat parameter, Multiple stepwise regression, Logistic regression, Diabetic vascular complications, Plasma Total homocysteine, Insulin intensive therapy, Folic acid, Vitamin B12
PDF Full Text Request
Related items